The combined effects of noise exposure and intravenous cisplatin injection on electrophysiologic hearing thresholds in guinea pigs were studied with short-term and long-term follow-up. The combined effects on the permanent threshold shift were dependent on the order of exposure. A potentiation was achieved when noise exposure preceded cisplatin injection by 30 minutes or by 3 days. Cisplatin injection 2 or 3 days before noise exposure produced no significant potentiation or inhibition. The combined effects on the temporary threshold shift were not influenced by the sequence of exposure.
HighbyD.J., WallaceH.J.Jr, AlbertD., HollandJ.F.Diamminedichloroplatinum in the chemotherapy of testicular tumors.J Urol1974; 112: 100–4.
2.
HayesD.M., CvitkovicE., GolbeyR.B., ScheinerE., HelsonL., KrakoffI.H.High dose cis-platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis.Cancer1977; 39: 1372–81.
3.
ReddelR.R., KeffordR.F., GrantJ.M., CoatesA.S., FoxR.M., TattersallM.H.N.Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.Cancer Treat Rep1982; 66: 19–23.
4.
VermorkenJ.B., KapteijnT.S., HartA.A.M., PinedoH.M.Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration.Eur J Cancer Clin Oncol1983; 19: 53–8.
5.
LaurellG., JungneliusU.High-dose cisplatin treatment: hearing loss and plasma concentrations.Laryngoscope1990; 100: 724–34.
6.
PielU., MeyerD., PerliaC.P., WolfeV.I.Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.Cancer Chemother Rep1974; 58: 871–5.
7.
KopelmanJ., BudnickA.S., SessionsR.B., KramerM.B., WongG.Y.Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.Laryngoscope1988; 98: 858–64.
BoettcherF.A., HendersonD., GrattonM.A., DanielsonR.W., ByrneC.D.Synergistic interactions of noise and other ototraumatic agents.Ear Hear1987; 8: 192–212.
10.
BrummettR.E.Ototoxicity resulting from the combined administration of potent diuretics and other agents.Scand Audiol [Suppl]1981(suppl 14): 215–24.
11.
KomuneS., SnowJ.B.Jr.Potentiating effects of cisplatin and ethacrynic acid in ototoxicity.Arch Otolaryngol1981; 107: 594–7.
12.
LaurellG., EngströmB.The combined effect of cisplatin and furosemide on hearing function in guinea pigs.Hear Res1989; 38: 19–26.
13.
McAlpineD., JohnstoneB.M.The ototoxic mechanism of cisplatin.Hear Res1990; 47: 191–204.
14.
SchweitzerV.G., HawkinsJ.E., LillyD.J.Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig.Otolaryngol Head Neck Surg1984; 92: 38–49.
15.
SchweitzerV.G., RareyK.E., DolanD.F., AbramsG.E., SheridanC.Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9).Laryngoscope1986; 96: 959–74.
16.
LaurellG., Bagger-SjöbäckD.Dose-dependent inner ear changes after i.v. administration of cisplatin.J Otolaryngol1991; 20: 158–67.
17.
FleischmanR.W., StadnickiS.W., EthierM.F., SchaeppiU.Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig.Toxicol Appl Pharmacol1975; 33: 320–32.
18.
EstremS.A., BabinR.W., RyuJ.H., MooreK.C.Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig.Otolaryngol Head Neck Surg1981; 89: 638–45.
19.
BarronS.E., DaigneaultE.A.Effect of cisplatin on hair cell morphology and lateral wall Na,K-ATPase activity.Hear Res1987; 26: 131–7.
20.
EngströmB.Stereocilia of sensory cells in normal and hearing impaired ears.Scand Audiol [Suppl]1983(suppl 19).
21.
FredeliusL., JohanssonB., Bagger-SjöbäckD., WersällJ.Qualitative and quantitative changes in the guinea pig organ of Corti after pure tone acoustic overstimulation.Hear Res1987; 30: 19–26.
22.
BorgE., EngströmB.Hearing thresholds in the rabbit. A behavioral and electrophysiological study.Acta Otolaryngol (Stockh)1983; 95: 19–26.
23.
KomuneS., AsakumaA., SnowJ.B.Jr.Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.Otolaryngol Head Neck Surg1981; 89: 275–82.
24.
LaurellG., EngströmB.The ototoxic effect of cisplatin on guinea pigs in relation to dosage.Hear Res1989; 38: 27–34.
25.
LimD.J.Ultrastructural cochlear changes following acoustic hyperstimulation and ototoxicity.Ann Otol Rhinol Laryngol1976; 85: 740–51.
26.
DeContiR.C., ToftnessB.R., LangeR.C., CreaseyW.A.Clinical and pharmacological studies with cis-diamminedichloroplatinum (U).Cancer Res1973; 33: 1310–5.
27.
PeraM.F., ZookB.C., HarderH.C.Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum (II) in rats.Cancer1979; 39: 1269–78.
28.
DayalV.S., KokshanianA., MitchellD.P.Combined effects of noise and kanamycin.Ann Otol Rhinol Laryngol1971; 80: 897–902.
29.
JauhiainenT., KohonenA., JauhiainenM.Combined effect of noise and neomycin on the cochlea.Acta Otolaryngol (Stockh)1972; 73: 387–90.
30.
BrownJ.J., BrummettR.E., FoxK.E., BendrickT.W.Combined effects of noise and kanamycin. Cochlear pathology and pharmacology.Arch Otolaryngol1980; 106: 744–50.
31.
MarquesD.M., ClarkC.S., HawkinsJ.E.Jr.Potentiation of cochlear injury by noise and ototoxic antibiotics in guinea pigs [Abstract].J Acoust Soc Am1975; 57(suppl 1): 60.
32.
LaurellG., BorgE.Ototoxicity of cisplatin in gynaecological cancer patients.Scand Audiol1988; 17: 241–7.
